{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:49Z","timestamp":1756902169951,"version":"3.44.0"},"reference-count":19,"publisher":"The Pediatric Pharmacy Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>The primary aim of this study was to determine continuation rates of stress ulcer prophylaxis (SUP) upon transfer from a pediatric intensive care unit (PICU) to a general medicine unit and upon hospital discharge. The secondary aim was to identify patient characteristics or concomitant medications that were associated with continuation of SUP at transfer from the PICU.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>This retrospective chart review included patients who were initiated on acid suppression for SUP in the PICU between June 2021 and May 2022 and subsequently transferred to a general medicine unit prior to discharge. Patients were excluded if they were receiving acid suppressant therapy prior to admission or were started on acid suppressants for an indication other than SUP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Two hundred three patients (median age, 3.3 years) were included. The rates of SUP continuation at the time of transfer from the PICU to a general medicine unit and at hospital discharge were 61.6% and 9.9%, respectively. Patients continued on SUP at the time of transfer from the PICU were more likely to be prescribed concomitant corticosteroids (p &amp;lt; 0.01), anticoagulants or antiplatelet medications (p &amp;lt; 0.01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The continuation of SUP from the PICU to the general medicine unit is common at our institution and calls into question the appropriateness of this practice. Future research is warranted to investigate the appropriateness of the continuation of SUP at transitions of care. Additionally, implementation of institutional protocols standardizing review of SUP may help reduce unnecessary prescribing of acid suppressants in general medicine units and at discharge.<\/jats:p>\n               <\/jats:sec>","DOI":"10.5863\/1551-6776-29.6.630","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T21:36:59Z","timestamp":1733780219000},"page":"630-635","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Stress Ulcer Prophylaxis in Pediatric General Medicine Patients After Transfer From the Intensive Care Unit and at Discharge"],"prefix":"10.5863","volume":"29","author":[{"given":"Lamees","family":"Loubani","sequence":"first","affiliation":[{"name":"Department of Pharmacy (LL, SL, JWB), Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna W.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (LL, SL, JWB), Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent","family":"Mothner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (BM, RA), Division of Pediatric Hospital Medicine, Baylor College of Medicine, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rathi","family":"Asaithambi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (BM, RA), Division of Pediatric Hospital Medicine, Baylor College of Medicine, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (LL, SL, JWB), Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"issue":"(6 suppl)","key":"2024121714202626000_i2331-348X-29-6-630-b01","doi-asserted-by":"crossref","first-page":"S351","DOI":"10.1097\/00003246-200206001-00002","article-title":"Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression","volume":"30","author":"Fennerty","year":"2002","journal-title":"Crit Care Med"},{"issue":"4","key":"2024121714202626000_i2331-348X-29-6-630-b02","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00130478-200110000-00002","article-title":"The impact of clinically significant upper gastrointestinal bleeding acquired in a pediatric intensive care unit","volume":"2","author":"Gauvin","year":"2001","journal-title":"Pediatr Crit Care Med"},{"key":"2024121714202626000_i2331-348X-29-6-630-b03","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpeds.2020.09.011","article-title":"Reassessing the use of proton pump inhibitors and histamine-2 antagonists in critically ill children: a systematic review and meta-analysis","volume":"228","author":"Yao","year":"2021","journal-title":"J Pediatr"},{"issue":"7","key":"2024121714202626000_i2331-348X-29-6-630-b04","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/PCC.0000000000000427","article-title":"Gastric acid suppressant prophylaxis in pediatric intensive care: current practice as reflected in a large administrative database","volume":"16","author":"Costarino","year":"2015","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"2024121714202626000_i2331-348X-29-6-630-b05","first-page":"525","article-title":"Stress ulcer prophylaxis in pediatric intensive care units","volume":"86","author":"Araujo","year":"2010","journal-title":"J Pediatr (Rio J)"},{"issue":"10","key":"2024121714202626000_i2331-348X-29-6-630-b06","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/PCC.0000000000000915","article-title":"Enteral nutrition and acid-suppressive therapy in the PICU: impact on the risk of ventilator associated pneumonia","volume":"17","author":"Albert","year":"2016","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"2024121714202626000_i2331-348X-29-6-630-b07","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajhp\/56.4.347","volume":"56","author":"ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis: ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998","year":"1999","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"2024121714202626000_i2331-348X-29-6-630-b08","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/PCC.0000000000002202","article-title":"Stress ulcer prophylaxis in critically ill children: a multicenter observational study","volume":"21","author":"Duffett","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"2024121714202626000_i2331-348X-29-6-630-b09","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1345\/aph.1K227","article-title":"Inappropriate continuation of stress ulcer prophylactic therapy after discharge","volume":"41","author":"Wohlt","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"8","key":"2024121714202626000_i2331-348X-29-6-630-b10","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1592\/phco.28.8.968","article-title":"Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit","volume":"28","author":"Murphy","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"10","key":"2024121714202626000_i2331-348X-29-6-630-b11","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1572-0241.2006.00839.x","article-title":"Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients","volume":"101","author":"Heidelbaugh","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"2024121714202626000_i2331-348X-29-6-630-b12","doi-asserted-by":"crossref","first-page":"741724","DOI":"10.3389\/fphar.2021.741724","article-title":"Pharmacist-led intervention on the inappropriate use of stress ulcer prophylaxis pharmacotherapy in intensive care units: a systematic review","volume":"12","author":"Xu","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"2024121714202626000_i2331-348X-29-6-630-b13","doi-asserted-by":"crossref","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","article-title":"Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis","volume":"4","author":"Narum","year":"2014","journal-title":"BMJ Open"},{"issue":"4","key":"2024121714202626000_i2331-348X-29-6-630-b14","doi-asserted-by":"crossref","first-page":"e2021054527","DOI":"10.1542\/peds.2021-054527","article-title":"Stress ulcer prophylaxis for critical asthma","volume":"149","author":"Roberts","year":"2022","journal-title":"Pediatrics"},{"issue":"1","key":"2024121714202626000_i2331-348X-29-6-630-b15","first-page":"e12759","article-title":"Adverse effects associated with proton pump inhibitor use","volume":"13","author":"Yibrin","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"2024121714202626000_i2331-348X-29-6-630-b16","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1542\/peds.2005-1655","article-title":"Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children","volume":"117","author":"Canani","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"2024121714202626000_i2331-348X-29-6-630-b17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jpeds.2014.06.062","article-title":"Association of Clostridium difficile infections with acid suppression medications in children","volume":"165","author":"Nylund","year":"2014","journal-title":"J Pediatr"},{"issue":"3","key":"2024121714202626000_i2331-348X-29-6-630-b18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1503\/cmaj.092129","article-title":"Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis","volume":"183","author":"Eom","year":"2011","journal-title":"CMAJ"},{"issue":"6","key":"2024121714202626000_i2331-348X-29-6-630-b19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jamapediatrics.2020.0007","article-title":"Association between proton pump inhibitor use and risk of fracture in children","volume":"174","author":"Wang","year":"2020","journal-title":"JAMA Pediatr"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/6\/630\/3465928\/i2331-348x-29-6-630.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/6\/630\/3465928\/i2331-348x-29-6-630.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:42:21Z","timestamp":1738780941000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/29\/6\/article-p630.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12,9]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-29.6.630","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"type":"electronic","value":"2331-348X"},{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}